Homecare, in a clinical context, refers to specialist healthcare services delivered directly to a person’s home rather than requiring them to attend a hospital or clinic. In the UK, this model is typically run by dedicated homecare providers who work in partnership with the NHS and pharmaceutical companies to deliver medicines and clinical support outside the hospital setting.

Services generally span two main areas:   

1) The supply and delivery of medicines and prescriptions (ensuring specialist or high-cost drugs are delivered to a person’s home safely, on time, and with correct storage and handling, such as cold-chain logistics for temperature-sensitive treatments), and  

2) Clinical nursing support, where trained homecare nurses visit patients to administer treatments, provide training on self-administration, monitor for side effects, and carry out routine clinical checks like bloods or observations. 

For those with Inherited Metabolic Disorders, homecare is particularly important because these are often lifelong, complex conditions requiring frequent, sometimes daily, administration of specialist medicines, enzyme replacement therapies, or dietary/formula products. Many with IMDs depend on strict treatment plans to prevent serious complications, so consistent, reliable access to medication is critical rather than optional. Requiring people, and often their families, to travel repeatedly to hospital for treatment places a significant burden on their time, finances, and quality of life. 

Homecare can remove much of this burden by bringing treatment to the individual, rather than the other way around. It reduces the frequency of hospital visits, freeing up hospital capacity for cases that genuinely need to be seen in person, while giving the individual (and their family) more control and freedom in daily life. It can also support better treatment adherence, since medicines and clinical support arrive consistently and on schedule, which is especially important for conditions where missed doses can lead to rapid clinical deterioration. Additionally, where it is possible, having a dedicated homecare nurse builds continuity of care and trust, as those with IMDs and those who care for them can develop an ongoing relationship with a healthcare professional who understands their specific condition, treatment history, and any personal circumstances, preferences, or challenges that may need to be considered to help them manage treatment well. 

In short, homecare providers act as an extension of the hospital service into the home, aiming to make complex, long-term treatment for IMDs more manageable, safer, and less disruptive to everyday life. 

Click the tiles below to navigate to the page you’re interested in: